Report date: Nov 6,2024
Conflict count: 361874
Publisher: National Institute for Health and Care Research
Title count: 5
Conflict count: 28


==========================================================

Created: 2024-05-16 10:57:33
ConfID: 7312055
CauseID: 1629134635
OtherID: 1593332193
JT: Efficacy and Mechanism Evaluation
MD: Hull,,,,2023,Research Article 3 - Polymorphisms in Cyclooxygenase, Lipoxygenase and TP53 genes predict colorectal polyp risk reduction by aspirin in the seAFOod polyp prevention trial
DOI: 10.3310/KPQW4935(Journal) (7312055-N)
DOI: 10.3310/JYTR3677(Journal)
==========================================================

Created: 2024-05-15 08:30:46
ConfID: 7309706
CauseID: 1628976291
OtherID: 1593332161
JT: Efficacy and Mechanism Evaluation
MD: Hull,,,,2023,Research Article 1 - Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use
DOI: 10.3310/FVCD8324(Journal) (7309706-N)
DOI: 10.3310/NJYT4687(Journal)